Table 1. HIV Antiretroviral Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. HIV Antiretroviral Therapy Market Restraints

Table 3. HIV Antiretroviral Therapy Market Trends

Table 4. HIV Antiretroviral Therapy Industry Policy

Table 5. Global HIV Antiretroviral Therapy Revenue by Company (2018-2023) & (US$ million)

Table 6. Global HIV Antiretroviral Therapy Revenue Market Share by Company (2018-2023)

Table 7. Global HIV Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global HIV Antiretroviral Therapy Mergers & Acquisitions, Expansion Plans

Table 9. Global HIV Antiretroviral Therapy Manufacturers Product Type

Table 10. China HIV Antiretroviral Therapy Revenue by Company (2018-2023) & (US$ million)

Table 11. China HIV Antiretroviral Therapy Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of HIV Antiretroviral Therapy Upstream (Raw Materials)

Table 13. Global HIV Antiretroviral Therapy Typical Customers

Table 14. HIV Antiretroviral Therapy Typical Distributors

Table 15. By Type, Global HIV Antiretroviral Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global HIV Antiretroviral Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global HIV Antiretroviral Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million

Table 19. By Country, Global HIV Antiretroviral Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million

Table 21. By Country, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029

Table 22. Gilead Company Information, Head Office, Market Area and Industry Position

Table 23. Gilead Company Profile and Main Business

Table 24. Gilead HIV Antiretroviral Therapy Models, Specifications and Application

Table 25. Gilead HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 26. Gilead Recent Developments

Table 27. Roche Company Information, Head Office, Market Area and Industry Position

Table 28. Roche Company Profile and Main Business

Table 29. Roche HIV Antiretroviral Therapy Models, Specifications and Application

Table 30. Roche HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 31. Roche Recent Developments

Table 32. ViiV Healthcare Company Information, Head Office, Market Area and Industry Position

Table 33. ViiV Healthcare Company Profile and Main Business

Table 34. ViiV Healthcare HIV Antiretroviral Therapy Models, Specifications and Application

Table 35. ViiV Healthcare HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 36. ViiV Healthcare Recent Developments

Table 37. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 38. Boehringer Ingelheim Company Profile and Main Business

Table 39. Boehringer Ingelheim HIV Antiretroviral Therapy Models, Specifications and Application

Table 40. Boehringer Ingelheim HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 41. Boehringer Ingelheim Recent Developments

Table 42. Johnson and Johnson Company Information, Head Office, Market Area and Industry Position

Table 43. Johnson and Johnson Company Profile and Main Business

Table 44. Johnson and Johnson HIV Antiretroviral Therapy Models, Specifications and Application

Table 45. Johnson and Johnson HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 46. Johnson and Johnson Recent Developments

Table 47. Mylan Company Information, Head Office, Market Area and Industry Position

Table 48. Mylan Company Profile and Main Business

Table 49. Mylan HIV Antiretroviral Therapy Models, Specifications and Application

Table 50. Mylan HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 51. Mylan Recent Developments

Table 52. Bionor Pharma Company Information, Head Office, Market Area and Industry Position

Table 53. Bionor Pharma Company Profile and Main Business

Table 54. Bionor Pharma HIV Antiretroviral Therapy Models, Specifications and Application

Table 55. Bionor Pharma HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 56. Bionor Pharma Recent Developments

Table 57. Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 58. Vertex Pharmaceuticals Company Profile and Main Business

Table 59. Vertex Pharmaceuticals HIV Antiretroviral Therapy Models, Specifications and Application

Table 60. Vertex Pharmaceuticals HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 61. Vertex Pharmaceuticals Recent Developments

Table 62. Merck Company Information, Head Office, Market Area and Industry Position

Table 63. Merck Company Profile and Main Business

Table 64. Merck HIV Antiretroviral Therapy Models, Specifications and Application

Table 65. Merck HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 66. Merck Recent Developments

Table 67. CIPLA Company Information, Head Office, Market Area and Industry Position

Table 68. CIPLA Company Profile and Main Business

Table 69. CIPLA HIV Antiretroviral Therapy Models, Specifications and Application

Table 70. CIPLA HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 71. CIPLA Recent Developments

Table 72. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 73. AbbVie Company Profile and Main Business

Table 74. AbbVie HIV Antiretroviral Therapy Models, Specifications and Application

Table 75. AbbVie HIV Antiretroviral Therapy Revenue and Gross Margin, 2018-2023

Table 76. AbbVie Recent Developments

List of Figure

Figure 1. HIV Antiretroviral Therapy Picture

Figure 2. Global HIV Antiretroviral Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China HIV Antiretroviral Therapy Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China HIV Antiretroviral Therapy Market Share of Global

Figure 5. Global HIV Antiretroviral Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global HIV Antiretroviral Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China HIV Antiretroviral Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China HIV Antiretroviral Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. HIV Antiretroviral Therapy Industry Chain

Figure 10. Nucleoside Reverse Transcriptase Inhibitors (NRTI)

Figure 11. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Figure 12. Protease Inhibitor (PI)

Figure 13. By Type, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Clinic

Figure 17. Other

Figure 18. By Application, Global HIV Antiretroviral Therapy Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029

Figure 20. By Region, Global HIV Antiretroviral Therapy Revenue Market Share, 2018-2029

Figure 21. North America HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America HIV Antiretroviral Therapy Revenue Market Share, 2018-2023

Figure 23. Europe HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe HIV Antiretroviral Therapy Revenue Market Share, 2018-2023

Figure 25. Asia Pacific HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific HIV Antiretroviral Therapy Revenue Market Share, 2018-2023

Figure 27. South America HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America HIV Antiretroviral Therapy Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa HIV Antiretroviral Therapy Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 32. By Type, U.S. HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 34. Europe HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 36. By Type, Europe HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 38. China HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 40. By Type, China HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 42. Japan HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 44. By Type, Japan HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 46. South Korea HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 48. By Type, South Korea HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 52. By Type, Southeast Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 54. India HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 56. By Type, India HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia HIV Antiretroviral Therapy Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia HIV Antiretroviral Therapy Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia HIV Antiretroviral Therapy Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches